| scholarly article | Q13442814 |
| P50 | author | Filippo Drago | Q18355267 |
| Michele Malaguarnera | Q80688977 | ||
| Marco Vacante | Q80688980 | ||
| Filippo Caraci | Q83164166 | ||
| Gaetano Bertino | Q30512640 | ||
| Salvatore Salomone | Q40856477 | ||
| Giulia Malaguarnera | Q47332750 | ||
| Mariano Malaguarnera | Q56847381 | ||
| Giuseppe Nunnari | Q57905511 | ||
| Caterina Gagliano | Q58806449 | ||
| P2093 | author name string | Manuela Pennisi | |
| P2860 | cites work | The validity and accuracy of the Work Productivity and Activity Impairment questionnaire--irritable bowel syndrome version (WPAI:IBS) | Q80424891 |
| Second-generation line probe assay for hepatitis C virus genotyping | Q27485722 | ||
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| Carnitine derivatives: clinical usefulness | Q28259745 | ||
| An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group | Q29614898 | ||
| Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin | Q33398403 | ||
| Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders | Q33628007 | ||
| Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement | Q34293132 | ||
| Carnitine function and requirements during the life cycle | Q35595604 | ||
| Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment | Q36080601 | ||
| Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review | Q36638638 | ||
| Quality of life considerations for patients with chronic hepatitis C. | Q37578733 | ||
| Acetyl-L-carnitine in hepatic encephalopathy | Q38079759 | ||
| Clinical pharmacology of novel anti-Alzheimer disease modifying medications | Q38127821 | ||
| A proposed system for the nomenclature of hepatitis C viral genotypes | Q43049109 | ||
| Fatigue in patients with chronic hepatitis C. | Q43549742 | ||
| Differences in epidemiology, liver disease and treatment response among HCV genotypes | Q43603868 | ||
| Sexual dysfunction in chronic hepatitis C virus patients treated with interferon alpha and ribavirin | Q45391194 | ||
| Predictors of mental and physical health in non-cirrhotic patients with viral hepatitis: a case control study | Q48408605 | ||
| The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin | Q48590661 | ||
| Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C. | Q48690015 | ||
| Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy | Q48886121 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects | Q73135842 | ||
| Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study | Q77834888 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ribavirin | Q421862 |
| P304 | page(s) | e11608 | |
| P577 | publication date | 2014-05-05 | |
| P1433 | published in | Hepatitis Monthly | Q15734417 |
| P1476 | title | Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial | |
| P478 | volume | 14 |
| Q26775011 | Chronic hepatitis C: This and the new era of treatment |
| Q64104306 | Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection |
| Q26750646 | Hepatocellular carcinoma and the risk of occupational exposure |
| Q38871856 | L-carnitine for cognitive enhancement in people without cognitive impairment. |
| Q38918313 | Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
| Q40078355 | Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance. |
| Q36192046 | Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability. |
| Q41426862 | Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin |
| Q39535683 | The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies |
Search more.